if you want to remove an article from website contact us from top.

    lung cancer alliance screening center of excellence

    James

    Guys, does anyone know the answer?

    get lung cancer alliance screening center of excellence from EN Bilgi.

    ACMH Named Screening Center of Excellence

    ACMH NAMED SCREENING CENTER OF EXCELLENCE

    Cancer Care

    ACMH joins an elite group of only 370+ Screening Centers across the country following Best Practices outlined by the Lung Cancer Alliance

    (Kittanning, PA) – ACMH has been named a Screening Center of Excellence by the Lung Cancer Alliance (LCA) for its ongoing commitment to responsible lung cancer screening. Low dose CT screening for lung cancer carried out safely, efficiently and equitably saves tens of thousands of lives a year.

    “We are proud and honored to be working with ACMH as a Lung Cancer Alliance Screening Center of Excellence. Their commitment to practice responsible lung cancer screening will lead to advancements in research and many lives saved. They are an example to follow,” says LCA President and CEO, Laurie Fenton Ambrose.

    Designated Screening Centers of Excellence are committed to provide clear information based on current evidence on who is a candidate for lung cancer screening, and to comply with comprehensive standards based on best practices developed by professional bodies such as the American College of Radiology (ACR), the National Comprehensive Cancer Network (NCCN) and the International Early Lung Cancer Action Program (I-ELCAP) for controlling screening quality, radiation dose and diagnostic procedures within an experienced, multi-disciplinary clinical setting.

    “ACMH is dedicated to providing patients with the highest quality care. Low dose CT screening has shown to be the only proven method to detect lung cancer at an early and treatable stage. We are thrilled to be part of this elite group, setting an example for responsible screening practices across the country,” says Dr. Erik Richter, Staff Cardiothoracic Radiologist of the Foundation Radiology Group.

    About Lung Cancer Alliance

    LCA is leading non-profit organization dedicated to saving lives and advancing research by empowering people living with or at risk for lung cancer. LCA provides live, professional support, referral and information services to patients, their loved ones and those at risk for lung cancer; conducts national awareness campaigns, including the award winning No One Deserves to Die Campaign attacking the stigma of the disease and the Moments Campaign, spreading word about the risk and screening with a risk navigator tool for consumers; and advocates for multiple millions in public health dollars for lung cancer research.

    Lung Cancer Alliance launched the National Framework for Excellence in Lung Cancer Screening and Continuum of Care in 2012 and now have over 370 sites committed to the guidelines. The National Framework lays out a bill of rights for the at-risk public and guiding principles for lung cancer screening sites.

    www.lungcanceralliance.org

    Source : www.acmh.org

    Become a Center of Excellence

    Facilities that commit to following best practices are eligible to become Lung Cancer Screening Centers of Excellence and enjoy the benefits.

    HelpLine 1-800-298-2436 [email protected]

    General Questions 202-463-2080 and 650-598-2857 [email protected]

    Become a Center of Excellence

    For Professionals

    History of Lung Cancer Screening

    Excellence in Screening and Care

    Other Resources

    Lung Cancer Social Worker of the Year Award

    Thoracic Oncology Business Model Tool

    Screening Program Structure Models

    Webinars

    Screening Guiding Principles

    Cost Effectiveness of Lung Cancer Screening

    Become a Center of Excellence

    Let’s Talk Screening

    National Screening Framework

    We offer technical assistance and support to help you apply and maintain one or both national Centers of Excellence designations meeting certain best practice criteria:

    Screening Center of Excellence (SCOE) designation recognizes medical facilities that provide responsible, high quality low-dose CT screening for early detection of lung cancer and comply with comprehensive standards based on best practices. SCOEs are guided by principles of patient-centered care and quality standards in screening delivery and management of findings so that the transformative stage-shift capacity and the life-saving promise of screening is realized. See below for current SCOE criteria.

    Care Continuum Center of Excellence (CCCOE) designation recognizes excellence in lung cancer care within community hospitals across the entire care continuum from screening and early detection through late stage diagnosis, care, treatment, support and survivorship.  CCCOEs aim to expand access to high quality multi-disciplinary care in the community setting where the majority of lung cancers are diagnosed.  See below for current CCCOE criteria.

    SCOE Criteria

    Join the nearly 800 medical facilities with the SCOE designation committed to responsible, high-quality screening practices and in compliance with comprehensive standards based on best practices developed by professional bodies such as the American College of Radiology (ACR), the National Comprehensive Cancer Network (NCCN) and the International Early Lung Cancer Action Program (I-ELCAP). Criteria include:

    Provide clear information on the risks and benefits of CT screening through a shared decision-making process.

    Comply with standards based on best published practices for controlling screening quality, radiation dose and diagnostic procedures.

    Work with a lung cancer multidisciplinary clinical team to carry out a coordinated process for screening, follow up and treatment when appropriate.

    Include a comprehensive cessation program for those still smoking or refer to comprehensive cessation programs.

    Report results to those screened and their primary care doctors and transmit requested copies in a timely manner.

    Have received or intend to receive designation as a lung cancer screening program through the American College of Radiology.

    Participation in annual data collection survey includes a free (confidential) metrics dashboard of your own data as well as the aggregated program data report.

    CCCOE Criteria

    Join the more than 60 medical facilities with the CCCOE designation recognizing community hospitals that treat lung cancer through a coordinated, multidisciplinary and patient-centric approach and demonstrating collaborative leadership across the lung cancer care continuum. Criteria include:

    Multi-disciplinary clinical team and tumor board approach

    Nurse Navigator

    LDCT screening program

    Nodule clinic

    Minimally invasive navigational bronchoscopy and thoracic surgical techniques

    Advanced diagnostics and pathology techniques including ROSE and molecular testing for all approved targets and immunotherapies including NGS and blood-based biopsies

    Referral opportunities for clinical trials

    Palliative care, shared-decision-making, and survivorship planning

    Patient-centric care

    Participation in the annual COE Impact Study

    For more information and to apply to become a Center of Excellence, please contact:

    SCOE – Robin Mohon – [email protected]; 202-774-5407

    CCCOE – Leah Fine – [email protected]; 650-598-2857

    Source : go2foundation.org

    Promoting Responsible Lung Cancer Screening Across the United States: Lessons From The Lung Cancer Alliance Screening Centers of Excellence

    Background and context: In 2010, the National Lung Screening Trial was halted in the United States after showing a 20% reduction in mortality for high risk individuals when three years of annual lung cancer screening was performed by low dose computed tomography (LDCT). Many questions remained about whether this type of screening could be properly implemented in nonacademic, community settings. Aim: Our aim was to promote high-quality, responsible lung cancer screening throughout the United States, including in community settings where most lung cancer is diagnosed. Strategy/Tactics: Lung Cancer Alliance developed a National Framework for Excellence in Lung Cancer Screening and Continuum of Care in 2012 and began a nationwide network dedicated to responsible lung cancer screening. The Screening Center of Excellence designation requires a center to ensure shared decision-making, comply with best practice standards, work with a multidisciplinary care team, refer for smoking cessation, provide results in a timely manner, and meet standards set by the American College of Radiology. Program/Policy process: From 2012 through 2016, over 500 centers were designated as Screening Centers of Excellence. These centers represented 42 states and more than 60% were from community/nonacademic community centers. High-risk individuals who come to the Lung Cancer Alliance Web site or contact the organization by phone to find a screening center are directed to a Center of Excellence. A data collection effort in 2017 collected comprehensive information about the state of lung cancer screening and care at their institution. Nearly 70% of centers responded to the survey. Outcomes: This program has helped promoted high quality lung cancer screening throughout the United States. Our program data shows that screening is being performed widely across the United States, including in nonacademic centers. For centers who were able to provide numbers of screenings performed and diagnoses, we identified a clear trend in diagnosis of Stage 1 lung cancer, indicating these screenings are able to find lung cancer early. We also identified a number of implementation challenges around referral patterns, insurance and billing, and determining appropriate risk criteria. What was learned: We have shown that a patient advocacy group working with medical professionals can help deliver high quality care to a broad population. Data collection from the Screening Centers of Excellence provides a snapshot of the state of lung cancer screening in the United States that underscores the success of LDCT and the importance of early detection but also identifies barriers in implementation that still need to be addressed.

    Article Tools

    TRACK 2 – ADVANCES IN SCREENING AND EARLY DETECTION

    TRACK 2 – ADVANCES IN SCREENING AND EARLY DETECTION Promoting Responsible Lung Cancer Screening Across the United States: Lessons From The Lung Cancer Alliance Screening Centers of Excellence

    A. Criswell, A. Ciupek, A. Copeland, J. King*

    Show More

    https://doi.org/10.1200/jgo.18.21800

    Abstract

    Abstract

    Background and context: In 2010, the National Lung Screening Trial was halted in the United States after showing a 20% reduction in mortality for high risk individuals when three years of annual lung cancer screening was performed by low dose computed tomography (LDCT). Many questions remained about whether this type of screening could be properly implemented in nonacademic, community settings. Aim: Our aim was to promote high-quality, responsible lung cancer screening throughout the United States, including in community settings where most lung cancer is diagnosed. Strategy/Tactics: Lung Cancer Alliance developed a National Framework for Excellence in Lung Cancer Screening and Continuum of Care in 2012 and began a nationwide network dedicated to responsible lung cancer screening. The Screening Center of Excellence designation requires a center to ensure shared decision-making, comply with best practice standards, work with a multidisciplinary care team, refer for smoking cessation, provide results in a timely manner, and meet standards set by the American College of Radiology. Program/Policy process: From 2012 through 2016, over 500 centers were designated as Screening Centers of Excellence. These centers represented 42 states and more than 60% were from community/nonacademic community centers. High-risk individuals who come to the Lung Cancer Alliance Web site or contact the organization by phone to find a screening center are directed to a Center of Excellence. A data collection effort in 2017 collected comprehensive information about the state of lung cancer screening and care at their institution. Nearly 70% of centers responded to the survey. Outcomes: This program has helped promoted high quality lung cancer screening throughout the United States. Our program data shows that screening is being performed widely across the United States, including in nonacademic centers. For centers who were able to provide numbers of screenings performed and diagnoses, we identified a clear trend in diagnosis of Stage 1 lung cancer, indicating these screenings are able to find lung cancer early. We also identified a number of implementation challenges around referral patterns, insurance and billing, and determining appropriate risk criteria. What was learned: We have shown that a patient advocacy group working with medical professionals can help deliver high quality care to a broad population. Data collection from the Screening Centers of Excellence provides a snapshot of the state of lung cancer screening in the United States that underscores the success of LDCT and the importance of early detection but also identifies barriers in implementation that still need to be addressed.

    © 2018 by American Society of Clinical Oncology

    Source : ascopubs.org

    Do you want to see answer or more ?
    James 5 month ago
    4

    Guys, does anyone know the answer?

    Click For Answer